EUROPEAN STROKE PREVENTION STUDY 2: DIPYRIDAMOLE AND ACETYLSALICYLIC ACID IN THE SECONDARY PREVENTION OF STROKE

SUMMARY In 1988, an optimal antiplatelet regimen for secondary stroke prevention remained to be defined. We undertook a randomised, placebo‐controlled, double‐blind trial to investigate the safety and efficacy of low‐dose acetylsalicylic acid (ASA), modified‐release dipyridamole, and the two agents ... View More